BROADWOOD PARTNERS, L.P. 4
4 · Insight Molecular Diagnostics Inc. · Filed Apr 20, 2026
Research Summary
AI-generated summary of this filing
IMDX 10% Owner Broadwood Partners Buys 182,861 Shares
What Happened
Broadwood Partners, L.P. (reported as a 10% owner) acquired a total of 182,861 shares of Insight Molecular Diagnostics, Inc. (IMDX) in a series of open-market/private purchases between April 16 and April 20, 2026. Transactions reported: 102,057 shares at $3.45 on 4/16 ($351,658); 40,114 shares at $3.57 on 4/17 ($143,251); and 40,690 shares at $3.88 on 4/20 (~$157,967). Aggregate value of these purchases is about $652,900. These were purchases (code P), not sales.
Key Details
- Transaction dates & prices: 4/16 @ $3.45 (102,057); 4/17 @ $3.57 (40,114); 4/20 @ $3.88 (40,690).
- Total shares acquired: 182,861; total consideration: ≈ $652,876.
- Shares owned after transaction: not stated in the filing.
- Footnotes of note:
- F1: Securities are directly owned by Broadwood Partners and may be deemed beneficially owned by Broadwood Capital, Inc. and Neal C. Bradsher; each disclaims beneficial ownership except to extent of pecuniary interest.
- F3–F5: Reported weighted-average prices cover ranges ($3.20–$3.99 across ranges); the filer will provide breakdowns of purchases at each price upon request.
- F6 noted (some warrants are currently exercisable) but the filing does not tie those warrants to these specific purchases.
- Filing timeliness: filing dated Apr 20, 2026 for transactions Apr 16–20; filing does not indicate a late report.
Context
- This report reflects institutional/investor purchases by a 10% owner, not an employee/board member trade. For retail investors, purchases by large holders can signal an increase in stake but are not a direct statement of company prospects.
- Transactions are simple purchases (code P); there are no option exercises, awards, or sales reported in this filing.
Insider Transaction Report
Form 4
BROADWOOD PARTNERS, L.P.
10% Owner
Transactions
- Purchase
Common Stock, no par value
[F3][F1]2026-04-16$3.45/sh+102,057$351,658→ 12,033,896 total - Purchase
Common Stock, no par value
[F1]2026-04-16+0→ 12,033,896 total(indirect: Footnote) - Purchase
Common Stock, no par value
[F4][F1]2026-04-17$3.57/sh+40,114$143,251→ 12,074,010 total - Purchase
Common Stock, no par value
[F1]2026-04-17+0→ 12,074,010 total(indirect: Footnote) - Purchase
Common Stock, no par value
[F5][F1]2026-04-20$3.88/sh+40,690$157,967→ 12,114,700 total - Purchase
Common Stock, no par value
[F1]2026-04-20+0→ 12,114,700 total(indirect: Footnote)
Holdings
- 157
Common Stock, no par value
[F2] - 150,093
Warrant to Purchase Common Stock
[F6][F1]Exercise: $30.60Exp: 2027-04-19→ Common Stock (150,093 underlying) - 150,093(indirect: Footnote)
Warrant to Purchase Common Stock
[F6][F1]Exercise: $30.60Exp: 2027-04-19→ Common Stock (150,093 underlying)
Footnotes (6)
- [F1]The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be beneficially owned by each of: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher, as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F2]These securities are directly owned by Neal C. Bradsher.
- [F3]This constitutes the weighted average purchase price. The prices range from $3.20 to $3.59. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F4]This constitutes the weighted average purchase price. The prices range from $3.45 to $3.84. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F5]This constitutes the weighted average purchase price. The prices range from $3.75 to $3.99. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F6]These warrants are currently exercisable.